CASSIDY QUIMBY: Open Payments
NPI 1740814441 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 85 payments from 18 companies in 2025. Trend: 2023 $1,443 · 2024 $1,993 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $268 |
| Ardelyx, Inc. | 8 | $176 |
| Lilly USA, LLC | 7 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Madrigal Pharmaceuticals | 6 | $117 |
| PFIZER INC. | 6 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $109 |
| QOL Medical, LLC | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $64 |
Products named: IBSRELA, DUPIXENT, OMVOH, REZDIFFRA, RINVOQ, Sucraid, RELISTOR, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
